MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. - Wikidata - wikimedia - TriplyDB

MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

http://www.wikidata.org/entity/Q33643242

about

Extracellular matrix and liver disease Epigenetics in liver disease Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Myofibroblasts Reversibility and heritability of liver fibrosis: Implications for research and therapy MicroRNAs in fibrosis: opportunities and challenges Epigenetics in liver disease: from biology to therapeutics Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization Genome-wide DNA methylation analysis in lung fibroblasts co-cultured with silica-exposed alveolar macrophages.DNA methylation in the tumor microenvironment.Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.Transdifferentiation: a cell and molecular reprogramming process.Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.miRNAs and cancer: an epigenetics view.Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells.Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression Rapid regulation of microRNA following induction of long-term potentiation in vivo Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cells The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.Cooperative regulation of substrate stiffness and extracellular matrix proteins in skin wound healing of axolotls Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2.Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.Morphogens and hepatic stellate cell fate regulation in chronic liver disease.Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells Fibrogenic cell reversion underlies fibrosis regression in liver.Role of MicroRNAs in Fibrosis.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis.Epigenetic regulation of miR-34a expression in alcoholic liver injury.Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure

P2860

Q26823060-937FCEF2-21A0-4715-B42F-FB9890DB6804 Q26849263-7960D157-2B32-4C2C-9A4F-8E4DB876CEC8 Q26863751-657C47D0-703F-4C2C-B847-0CFC10555A9C Q27022840-26D98FD8-A0AE-4FE3-A9D4-718F3B804A85 Q27026622-A6A8DB69-D07B-4EA6-AF3F-A03C6E230530 Q28067380-B1A84676-2525-402F-8A23-38FF911B9ED4 Q28079271-E736D18E-D88C-4D9F-B509-C56A2BF60800 Q28269801-20DE5C8C-8D89-49BE-8CC3-D746ACE21521 Q28272678-C8486D57-1DC2-44F6-8605-12D75DFB5A65 Q28476642-0A72CFCE-E523-4E3B-8907-529EE2D5369B Q28909812-7C68B66C-17FA-4A9C-BEF1-7F250CD5472A Q33677179-148FE542-D300-4285-802D-5E032796784D Q33722994-6C8A9263-2A91-4D6D-B6BF-C1698263CFFD Q33734913-A4CA5E97-4E0B-4714-B6BF-AF22AF06A38B Q33769492-58C59026-0A70-40FE-8EC0-10B8B3EA2801 Q34031587-4B5D6242-727B-49D8-8B32-27DAC91D6AB9 Q34036012-9F9159A6-7F75-4A14-9146-2970027C476B Q34155250-B3381795-68B0-470D-84C6-286C1617836E Q34286618-EB68A77A-BBB0-4B6A-AB28-AB18E9F8A66A Q34333224-9A6B8290-F99B-4D42-8D98-08FAC1506A34 Q34473076-0E75E7A4-280A-4D89-853E-281C22721542 Q34660735-79F80F23-C27A-44F1-ABB0-6C532BE53203 Q34805635-9AD10984-6113-4C77-888D-071037BD0196 Q34856311-160A2763-3A2D-44BB-AC5E-9577DA6B4078 Q35055339-0249E9C8-06BF-4EA9-B248-2B1DBDECF7BA Q35180703-AAEEB52E-0D0E-4B49-807F-FB4B0954738A Q35207548-10EA07ED-4AEF-4175-8200-F4A65B4CC4F8 Q35329148-1D7F968C-2779-4071-B88C-9521B2BD5530 Q35531772-044F27EE-A356-4ED0-91D9-3D994435FFA6 Q35880000-21628F16-85E8-493B-931E-9E77AF4DA220 Q35914173-0F1D4EEB-5ED0-4759-9634-C8EFF35C3157 Q35965687-987A36C1-9894-4425-B695-4BE66B3740A8 Q36008844-9BB9EB93-89AD-44FD-B861-A21991731FEC Q36026774-560BA5E9-3E32-4287-828E-BA09F1EB658D Q36066433-2A63253C-AD0F-4005-A470-6F14A08AA818 Q36093326-D5397F99-009A-4E20-8699-12BA6790BA94 Q36093802-849FE9AD-572E-46FC-8CEB-FD47ABFDA03C Q36113039-22856B50-22BB-4C8F-869D-F835E91C57FA Q36204201-54005A30-0884-4154-83AA-5824FEBCE160 Q36224015-631AB80B-FAAE-494D-8D05-782CA4252522

P2860

MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

http://www.wikidata.org/entity/Q33643242

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@ast

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@en

type

label

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@ast

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@en

prefLabel

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@ast

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@en

P1433

Q33643242-3140FCB2-EBE6-46DF-B233-36171CD9F2FB

P1476

Q33643242-A652AD63-DF3A-4F84-9095-F08726B6D572

P2093

Q33643242-45B618CC-41BD-4028-8397-34F25DA977D6

Q33643242-4731B912-FBE0-487C-A1BD-9EAE0A058C95

Q33643242-78D2C565-3008-4489-A5BA-81630D939E66

Q33643242-AF61E74D-6CBE-4197-8C76-CA0A439802F7

Q33643242-D1D19F74-A1AD-46EF-BFD9-56DF79615FFC

Q33643242-F10DAACE-C802-4829-AEC6-39AD407C186C

Q33643242-FB31A86D-54A5-404D-A994-87E730BEE35E

P2860

Q33643242-0A2666FD-7316-442D-8F16-999288546260

Q33643242-0E494E4B-3AD6-4DC9-9BC5-ECCCA0E24FC5

Q33643242-0ECCE832-34E6-438B-808C-5F48C718EE5F

Q33643242-104A0F95-6577-41D5-80D0-C84F419B54F9

Q33643242-109BBDE4-C87B-418F-A777-DCA5A201DFCD

Q33643242-144F8AF3-FD5E-435A-8989-E274E08800C4

Q33643242-16F25593-A0A6-498E-914C-C22FDCDBA5F6

Q33643242-357F6218-7705-41D8-ADD5-A5B96121636F

Q33643242-367E076C-6215-4D68-9A98-7F13A5536484

Q33643242-403AE99E-3689-493A-B9ED-57B074720F98

P304

Q33643242-98AF41C7-AE45-46CB-BE04-4F2071D0E1FB

P31

Q33643242-3F109E15-3D98-4843-A40C-3080D07F031D

P356

Q33643242-5245E092-39FF-42CE-A5C5-59B50EA0B412

P407

Q33643242-F86BF810-9320-4F88-A8DB-A8CCBBC012EC

P433

Q33643242-CBFED513-B42C-4873-9D74-6E6432D529B3

P478

Q33643242-66D4F777-D342-4AAD-80F5-F6C64DD203DE

P577

Q33643242-50127063-A661-4D5F-AED8-276351F787BA

P5875

Q33643242-E6AA78D0-9F3D-43E9-B520-F734BDE0A9BF

P698

Q33643242-4CB57BA6-70F7-496A-935F-AB9177BAB8DE

P932

Q33643242-2F162962-0E1F-4A82-9EFC-885A7FD71358

P356

J.GASTRO.2009.10.002

P1433

Gastroenterology

P1476

MeCP2 controls an epigenetic p ...... sdifferentiation and fibrosis.

@en

P2093

Aidan Maxwell

http://www.w3.org/2001/XMLSchema#string

David C K Chu

http://www.w3.org/2001/XMLSchema#string

Derek A Mann

http://www.w3.org/2001/XMLSchema#string

Fiona Oakley

http://www.w3.org/2001/XMLSchema#string

Hidekazu Tsukamoto

http://www.w3.org/2001/XMLSchema#string

Jelena Mann

http://www.w3.org/2001/XMLSchema#string

Nian-Ling Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

MeCP2, a key contributor to neurological disease, activates and represses transcription

Cellular and molecular mechanisms of fibrosis

The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase

Maintenance of stable heterochromatin domains by dynamic HP1 binding

Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA

Polycomb silencing mechanisms and the management of genomic programmes

The diverse functions of histone lysine methylation

Epigenetics: a landscape takes shape

Recent advances in MeCP2 structure and function.

Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

P304

705-14, 714.e1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.10.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38024455

http://www.w3.org/2001/XMLSchema#string

P698

19843474

http://www.w3.org/2001/XMLSchema#string

P932

2819585

http://www.w3.org/2001/XMLSchema#string